Kraig Biocraft Laboratories (KBLB) Return on Capital Employed (2011 - 2025)

Kraig Biocraft Laboratories (KBLB) has 13 years of Return on Capital Employed data on file, last reported at 42.27% in Q4 2025.

• For the quarter ending Q4 2025, Return on Capital Employed rose 310.0% year-over-year to 42.27%; the trailing twelve-month figure through Dec 2025 stood at 42.27% (up 310.0% YoY), and the FY2025 full-year result was 40.13%, down 231.0% from the prior year.
• Return on Capital Employed grew to 42.27% in Q4 2025, from 41.02% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 64.45% in Q4 2022 to a low of 27.49% in Q2 2025.
• A 5-year average of 47.26% and a median of 47.11% in 2023 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed tumbled 6335 bps in 2021 and soared 2106 bps in 2022, its largest moves.
• Tracing KBLB's Return on Capital Employed over 5 years: stood at 55.36% in 2021, then rose by 16 bps to 64.45% in 2022, then retreated by 26 bps to 47.93% in 2023, then dropped by 18 bps to 39.17% in 2024, then grew by 8 bps to 42.27% in 2025.
• Business Quant data shows KBLB's Return on Capital Employed at 42.27% in Q4 2025, 41.02% in Q3 2025, and 27.49% in Q2 2025.